Cargando…
Retinal vein changes after treatment with aflibercept and PRP in high-risk proliferative diabetic retinopathy
OBJECTIVE: The objective of the study was to investigate the effectiveness of aflibercept and panretinal photocoagulation (PRP) in the treatment of proliferative diabetic retinopathy (PDR). METHODS: A retrospective analysis was performed on 59 patients (59 eyes) with high-risk PDR who were treated w...
Autores principales: | Zhao, Hui, Wang, Jundong, Li, Shuting, Bao, Ying, Zheng, Xiaoxia, Tao, Yuan, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034169/ https://www.ncbi.nlm.nih.gov/pubmed/36968838 http://dx.doi.org/10.3389/fmed.2023.1090964 |
Ejemplares similares
-
Intravitreal aflibercept partially reverses severe non-proliferative diabetic retinopathy in treatment-naïve patients
por: Tao, Yuan, et al.
Publicado: (2021) -
Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study
por: Si, Mingwei, et al.
Publicado: (2023) -
Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
por: Halim, Sandra, et al.
Publicado: (2021) -
Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
por: Xie, Xiao, et al.
Publicado: (2023) -
Retinal and choroidal microvascular characterization and density changes in different stages of diabetic retinopathy eyes
por: Wang, Hui, et al.
Publicado: (2023)